Cargando…

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses

The novel coronavirus SARS-CoV-2 is the seventh identified human coronavirus. Understanding the extent of pre-existing immunity induced by seropositivity to endemic seasonal coronaviruses and the impact of cross-reactivity on COVID-19 disease progression remains a key research question in immunity t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sampson, Alexander Thomas, Heeney, Jonathan, Cantoni, Diego, Ferrari, Matteo, Sans, Maria Suau, George, Charlotte, Di Genova, Cecilia, Mayora Neto, Martin, Einhauser, Sebastian, Asbach, Benedikt, Wagner, Ralf, Baxendale, Helen, Temperton, Nigel, Carnell, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402765/ https://www.ncbi.nlm.nih.gov/pubmed/34452443 http://dx.doi.org/10.3390/v13081579

Ejemplares similares

Human seasonal coronavirus neutralization and COVID‐19 severity
por: Wells, David A., et al.
Publicado: (2022)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design
por: da Costa, Kelly A. S., et al.
Publicado: (2022)

The Use of Retroviral Pseudotypes for the Measurement of Antibody Responses to SARS Coronavirus
por: Temperton, Nigel James
Publicado: (2009)

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
por: Cantoni, Diego, et al.
Publicado: (2023)

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2021)

Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016)

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
por: Ferrara, Francesca, et al.
Publicado: (2018)

Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds
por: Cantoni, Diego, et al.
Publicado: (2022)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
por: Carnell, George W., et al.
Publicado: (2023)

Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
por: Nadesalingam, Angalee, et al.
Publicado: (2021)

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
por: Cantoni, Diego, et al.
Publicado: (2022)

Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines
por: Carnell, George W., et al.
Publicado: (2021)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison
por: Wright, Edward, et al.
Publicado: (2008)

Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies
por: Aguinam, Ernest T., et al.
Publicado: (2023)

Comparison of lentiviruses pseudotyped with S proteins from coronaviruses and cell tropisms of porcine coronaviruses
por: Wang, Jingjing, et al.
Publicado: (2016)

The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination()
por: Bentley, Emma M., et al.
Publicado: (2015)

The use of equine influenza pseudotypes for serological screening
por: Scott, Simon, et al.
Publicado: (2012)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies
por: Ferrara, Francesca, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses
por: Carnell, George W., et al.
Publicado: (2021)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay
por: Genova, Cecilia Di, et al.
Publicado: (2023)

The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
por: Scott, Simon D., et al.
Publicado: (2016)

Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation
por: Beirag, Nazar, et al.
Publicado: (2022)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus
por: Chan, C.M., et al.
Publicado: (2009)

Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of Sars Coronavirus Spike Protein
por: Fukushi, Shuetsu, et al.
Publicado: (2006)

Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
por: Castillo-Olivares, Javier, et al.
Publicado: (2021)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
por: Grehan, K., et al.
Publicado: (2015)

The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
por: Zettl, Ferdinand, et al.
Publicado: (2020)

Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
por: Lin, Han-Xin, et al.
Publicado: (2011)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5e7jidj4sb41kqp8gb6cckg0m0